Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Valeos Pharma A/S
A/S
Active
Advertising protection
CVR 39696614
Østervej 2, 4960
Holeby
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2018 · 7 years old
19 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
Valeos Pharma A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2020
-3M
2021
-6M
2022
-6M
2023
-4M
2024
EBITDA
DKK millions
0M
-5M
-9M
-14M
-19M
-2M
2020
-7M
-250%
2021
-13M
-86%
2022
-15M
-15%
2023
-14M
+7%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-1.277
-3.379
-6.489
-5.839
-3.847
Staff expenses
-702
-4.014
-6.837
-9.039
-10.559
EBITDA
-1.979
-7.393
-13.326
-14.877
-14.405
Depreciation & amort.
-0
-20
-54
-2.354
-3.114
EBIT
-1.979
-7.413
-13.380
-17.231
-17.519
Net financials
-194
-797
-1.256
-3.937
-4.182
Profit before tax
-2.173
-8.209
-14.637
-21.168
-21.701
Tax
-468
-1.801
-3.211
-4.634
-4.756
Net profit
-1.705
-6.408
-11.426
-16.534
-16.945
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
22.247
49.945
57.322
61.095
58.144
Equity
-1.416
16.532
5.106
-8.428
6.800
Long-term debt
22.235
31.108
34.710
46.510
29.671
Short-term debt
1.428
2.300
17.498
23.013
20.518
Total debt
23.664
33.408
52.208
69.523
50.190
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1440542000.0%
This company
2020
2024
Equity ratio
11.7%
This company
38.2%
Market median
-69% vs market
2020
2024
Return on equity
-249.2%
This company
18.4%
Market median
-1454% vs market
2020
2024
Net profit margin (of gross profit)
-1694471000.0%
This company
2020
2024
Asset turnover (of gross profit)
-0.07×
This company
2020
2024
Debt / equity
7.55×
This company
0.62×
Market median
-1118% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Valeos Pharma A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
